PITACAB-C-500
MRP: 110
Packaging: 2ML
Pack Type: injection
Composition:
Citicoline 500 mg
Indication:
Acute and Recovery phase of Cerebral Infarction (e.g. ischemia due to stroke). Cognitive dysfunction due to degenerative (Alzheimers disease) and cerebrovascular disease. Cerebral insufficiency (e.g, dizziness, memory loss, poor concentration, disorient
Description:
Citicoline 500 mg is a neuroprotective agent used in the treatment of acute ischemic stroke, traumatic brain injury (TBI), cognitive dysfunction, Parkinson’s disease, and vascular dementia. It acts as a brain cell regenerator by enhancing the synthesis of phosphatidylcholine, an essential component of the neuronal membrane.
Citicoline improves neuronal membrane repair, cerebral blood flow, and neurotransmitter levels, making it ideal for both acute and long-term neurological recovery.
It is available in injection form (IM/IV) for hospital settings, ensuring rapid delivery during critical neurological episodes.
Tags:
- Promotes neuroprotection and neurorepair
- Enhances cognitive function and memory recall
- Supports recovery post stroke and TBI
- Improves choline and acetylcholine synthesis
- Aids in delaying dementia progression
Usage Information
Dosage
Route: IM (intramuscular) or IV (intravenous) Typical Dose: 500 mg once or twice daily depending on the condition In acute stroke, initial IV therapy may continue for 10–15 days Always to be administered under medical supervision
Side Effects
Mild headache Insomnia or restlessness Nausea or digestive discomfort Injection site pain Rare: Hypotension or bradycardia in sensitive patients
Contraindications
Hypersensitivity to Citicoline or excipients Intracranial hemorrhage (use with caution) Pregnancy & lactation (only if prescribed) Use with caution in patients with epilepsy or psychiatric disorders
Availability
Citicoline 500 mg injection Brain stroke recovery medicine Neuroprotective injection Citicoline for TBI and stroke Cognitive enhancer injectable Injection for neuroregeneration